CD274 and classic Hodgkin lymphoma: Currently, in the lymphoma setting, most studies have focused on PD1/PDL1 blockade, which has shown dramatic effects in cHL and primary mediastinal large B-cell lymphoma but less so in other subtypes such as DLBCL.